Dyne Therapeutics, Inc. (DYN) stock

DYNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30

$17.01−0.98 (-5.45%)

Close on Nov 12, 2026Market cap $3.18BP/E –Yield –

Dyne Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Dyne Therapeutics's total debt was $9.94M at Sep 30, 2020.

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2020	Sep 30, 2020	$9.94M	–

See a number that looks wrong?